428 related articles for article (PubMed ID: 28251499)
1. Comparison of gadoxetic acid-enhanced dynamic MR imaging and contrast-enhanced computed tomography for preoperative evaluation of colorectal liver metastases.
Asato N; Tsurusaki M; Sofue K; Hieda Y; Katsube T; Kitajima K; Murakami T
Jpn J Radiol; 2017 Apr; 35(4):197-205. PubMed ID: 28251499
[TBL] [Abstract][Full Text] [Related]
2. Does Gadoxetic acid-enhanced 3.0T MRI in addition to 64-detector-row contrast-enhanced CT provide better diagnostic performance and change the therapeutic strategy for the preoperative evaluation of colorectal liver metastases?
Sofue K; Tsurusaki M; Murakami T; Onoe S; Tokue H; Shibamoto K; Arai Y; Sugimura K
Eur Radiol; 2014 Oct; 24(10):2532-9. PubMed ID: 24865698
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI.
Muhi A; Ichikawa T; Motosugi U; Sou H; Nakajima H; Sano K; Sano M; Kato S; Kitamura T; Fatima Z; Fukushima K; Iino H; Mori Y; Fujii H; Araki T
J Magn Reson Imaging; 2011 Aug; 34(2):326-35. PubMed ID: 21780227
[TBL] [Abstract][Full Text] [Related]
4. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
[TBL] [Abstract][Full Text] [Related]
5. Comparison of gadoxetic acid-enhanced dynamic imaging and diffusion-weighted imaging for the preoperative evaluation of colorectal liver metastases.
Chung WS; Kim MJ; Chung YE; Kim YE; Park MS; Choi JY; Kim KW
J Magn Reson Imaging; 2011 Aug; 34(2):345-53. PubMed ID: 21702068
[TBL] [Abstract][Full Text] [Related]
6. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
7. Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques.
Kim HJ; Lee SS; Byun JH; Kim JC; Yu CS; Park SH; Kim AY; Ha HK
Radiology; 2015 Mar; 274(3):712-22. PubMed ID: 25286324
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of Routine Application of Gadoxetic Acid-Enhanced MRI in Combination with Diffusion-Weighted MRI for the Preoperative Evaluation of Colorectal Liver Metastases.
Tanaka M; Kishi Y; Esaki M; Nara S; Miyake M; Hiraoka N; Nagino M; Shimada K
Ann Surg Oncol; 2016 Nov; 23(12):3991-3998. PubMed ID: 27357179
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of gadoxetic acid-enhanced liver MRI versus multidetector CT in the assessment of colorectal liver metastases compared to hepatic resection.
Granata V; Fusco R; de Lutio di Castelguidone E; Avallone A; Palaia R; Delrio P; Tatangelo F; Botti G; Grassi R; Izzo F; Petrillo A
BMC Gastroenterol; 2019 Jul; 19(1):129. PubMed ID: 31340755
[TBL] [Abstract][Full Text] [Related]
10. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.
Donati OF; Hany TF; Reiner CS; von Schulthess GK; Marincek B; Seifert B; Weishaupt D
J Nucl Med; 2010 May; 51(5):692-9. PubMed ID: 20395324
[TBL] [Abstract][Full Text] [Related]
11. Prospective comparison of gadoxetic acid-enhanced liver MRI and contrast-enhanced CT with histopathological correlation for preoperative detection of colorectal liver metastases following chemotherapy and potential impact on surgical plan.
Jhaveri KS; Fischer SE; Hosseini-Nik H; Sreeharsha B; Menezes RJ; Gallinger S; Moulton CE
HPB (Oxford); 2017 Nov; 19(11):992-1000. PubMed ID: 28760631
[TBL] [Abstract][Full Text] [Related]
12. Comparison of contrast-enhanced ultrasonograpy with Gd-EOB-DTPA-enhanced MRI in the diagnosis of liver metastasis from colorectal cancer.
Shiozawa K; Watanabe M; Ikehara T; Matsukiyo Y; Kogame M; Kikuchi Y; Otsuka Y; Kaneko H; Igarashi Y; Sumino Y
J Clin Ultrasound; 2017 Mar; 45(3):138-144. PubMed ID: 27861987
[TBL] [Abstract][Full Text] [Related]
13. Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT.
Motosugi U; Ichikawa T; Morisaka H; Sou H; Muhi A; Kimura K; Sano K; Araki T
Radiology; 2011 Aug; 260(2):446-53. PubMed ID: 21693662
[TBL] [Abstract][Full Text] [Related]
14. Routine Preoperative Liver-specific Magnetic Resonance Imaging Does Not Exclude the Necessity of Contrast-enhanced Intraoperative Ultrasound in Hepatic Resection for Colorectal Liver Metastasis.
Arita J; Ono Y; Takahashi M; Inoue Y; Takahashi Y; Matsueda K; Saiura A
Ann Surg; 2015 Dec; 262(6):1086-91. PubMed ID: 26010441
[TBL] [Abstract][Full Text] [Related]
15. Management of disappearing lesions after chemotherapy for colorectal liver metastases: Relation between detectability and residual tumors.
Tani K; Shindoh J; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
J Surg Oncol; 2018 Feb; 117(2):191-197. PubMed ID: 28876456
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic performance of gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced multi-detector computed tomography in detecting hepatocellular carcinoma: a meta-analysis of eight prospective studies.
Li J; Wang J; Lei L; Yuan G; He S
Eur Radiol; 2019 Dec; 29(12):6519-6528. PubMed ID: 31250172
[TBL] [Abstract][Full Text] [Related]
17. Additional value of gadoxetic acid-DTPA-enhanced hepatobiliary phase MR imaging in the diagnosis of early-stage hepatocellular carcinoma: comparison with dynamic triple-phase multidetector CT imaging.
Haradome H; Grazioli L; Tinti R; Morone M; Motosugi U; Sano K; Ichikawa T; Kwee TC; Colagrande S
J Magn Reson Imaging; 2011 Jul; 34(1):69-78. PubMed ID: 21598343
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid.
Semaan S; Vietti Violi N; Lewis S; Chatterji M; Song C; Besa C; Babb JS; Fiel MI; Schwartz M; Thung S; Sirlin CB; Taouli B
Eur Radiol; 2020 Feb; 30(2):1020-1030. PubMed ID: 31673837
[TBL] [Abstract][Full Text] [Related]
19. Is MRI of the Liver Needed During Routine Preoperative Workup for Colorectal Cancer?
Kang SI; Kim DW; Cho JY; Park J; Lee KH; Son IT; Oh HK; Kang SB
Dis Colon Rectum; 2017 Sep; 60(9):936-944. PubMed ID: 28796732
[TBL] [Abstract][Full Text] [Related]
20. Comparative diagnostic accuracy of hepatocyte-specific gadoxetic acid (Gd-EOB-DTPA) enhanced MR imaging and contrast enhanced CT for the detection of liver metastases: a systematic review and meta-analysis.
Vreugdenburg TD; Ma N; Duncan JK; Riitano D; Cameron AL; Maddern GJ
Int J Colorectal Dis; 2016 Nov; 31(11):1739-1749. PubMed ID: 27682648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]